Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1139-1143

  Kamel, M H ^a   Daly, P J ^a   Khan, M F ^a   Kay, E W ^a   O'Kelly, P ^a   Hickey, D P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Bladder; Cancer; Grade; Progression; Superficial; Survival

Indexed keywords

BCG MEDAC; BCG VACCINE; EPIRUBICIN; EPIRUBICIN BAXTER;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 33751159630     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.04.006     Document Type: Article

References (12)

1. Epstein J.I. The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?. Crit Rev Oncol/Hematol 47 (2003) 83-89
2. Epstein J.I., Amin M.B., Reuter V.E., and Mostofi F.K. The World Health Organization/International Society of Urological Pathology consensus classification of Urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1448
3. Holmang S., Andius P., Hedelin H., Wester K., Busch C., and Johansson S.L. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 165 (2001) 1124-1128
4. Lopez-Beltran A., and Rodolfo Montironi R. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol 46 (2004) 170-176
5. Samaratunga H., Markov D.V., and Epstein J.I. Comparison of WHO/ISUP classification of non-invasive papillary urothelial neoplasms for risk of progression. Urology 60 (2002) 315-319
6. Curry J.L., and Wojcik E.M. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer 96 (2002) 140-145
7. Holmang S., and Johansson S.L. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Urology 66 (2005) 274-278
8. van der Meijden A.P., Sylvester R., Oosterlinck W., et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 48 (2005) 363-371
9. Oosterlinck W., Lobel B., Jakse G., Malmstrom P.U., Stockle M., Sternberg C., and European Association of Urology (EAU) Working Group on Oncological Urology. Guidelines on bladder cancer. Eur Urol 41 (2002) 105-112
10. Herr H.W. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19 (2001) 89-93
11. Solsona E., Iborra I., Monros J.L., Casanova J., and Calabuig C. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term follow up of a prospective study. J Urol 159 (1998) 95-98
12. Dalbagni G., Herr H.W., and Reuter V.E. Impact of second transurethral resection on the staging of T1 bladder cancer. Urology 60 (2002) 824-825